Blocking a receptor involved in prostaglandins reduces pain while allowing inflammation to proceed normally, according to findings from animal and cell studies. Researchers at the NYU Pain Research Center have pinpointed the specific receptor within prostaglandins, the hormone-like compounds targeted by many pain medications, that triggers pain but not inflammation. Their findings, published in Nature […]
Source link